» Articles » PMID: 10368869

Glucose Tolerance and Serum Insulin Levels in an Animal Model of Obesity Induced by Sub-acute or Chronic Administration of Antipsychotic Drugs

Overview
Specialty Psychiatry
Date 1999 Jun 16
PMID 10368869
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

1. To assess the role of insulin in the development of the obesity induced by antipsychotic drugs, a glucose tolerance test was conducted in female rats after 0 or 30 days of sulpiride administration. 2. At day 10, the area under the glucose curve did not differ between sulpiride and vehicle-treated rats, however, the area under the insulin curve was significantly decreased by sulpiride. At day, 30 the insulin response was similar in both groups, but the area under the glucose curve was significantly lower in the sulpiride-treated rats. 3. The results suggest that insulin resistance and hyperinsulinemia are not involved in the development and maintenance of the obesity induced by sulpiride. Contrarily, these findings may be related to an increased insulin sensitivity. 4. The absence of hyperinsulinemia and insulin resistance indicates important differences between primary obesity in humans and rodents and this model of drug-induced excessive weight gain.

Citing Articles

Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance.

Boyda H, Pham M, Huang J, Ho A, Procyshyn R, Yuen J Front Pharmacol. 2022; 13:765905.

PMID: 35242029 PMC: 8886888. DOI: 10.3389/fphar.2022.765905.


Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.

Citrome L, Holt R, Walker D, Poole Hoffmann V Clin Drug Investig. 2011; 31(7):455-82.

PMID: 21495734 DOI: 10.2165/11589060-000000000-00000.


The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

Fell M, Anjum N, Dickinson K, Marshall K, Peltola L, Vickers S Psychopharmacology (Berl). 2007; 194(2):221-31.

PMID: 17581744 DOI: 10.1007/s00213-007-0833-9.


Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

Holt R, Peveler R Diabetologia. 2006; 49(7):1467-76.

PMID: 16752165 DOI: 10.1007/s00125-006-0279-3.


Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.

Kalinichev M, Rourke C, Daniels A, Grizzle M, S Britt C, Ignar D Psychopharmacology (Berl). 2005; 182(2):220-31.

PMID: 16001110 DOI: 10.1007/s00213-005-0081-9.